SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011879
Filing Date
2018-05-08
Accepted
2018-05-08 16:37:59
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2018 10-Q snss-10q_20180331.htm 10-Q 945331
2 EX-31.1 snss-ex311_8.htm EX-31.1 16667
3 EX-31.2 snss-ex312_6.htm EX-31.2 16841
4 EX-32.1 snss-ex321_7.htm EX-32.1 8167
5 GRAPHIC g201805081824214732854.jpg GRAPHIC 3336
  Complete submission text file 0001564590-18-011879.txt   3333187

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20180331.xml EX-101.INS 611154
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20180331.xsd EX-101.SCH 33835
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20180331_cal.xml EX-101.CAL 33488
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20180331_def.xml EX-101.DEF 92706
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20180331_lab.xml EX-101.LAB 242500
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20180331_pre.xml EX-101.PRE 161726
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 18815232
SIC: 2834 Pharmaceutical Preparations